Export 20 results:
Author Title [ Type(Desc)] Year
Filters: Author is Rouphael, Nadine  [Clear All Filters]
Journal Article
K. M. Maner-Smith, Goll, J. B., Khadka, M., Jensen, T. L., Colucci, J. K., Gelber, C. E., Albert, C. J., Bosinger, S. E., Franke, J. D., Natrajan, M., Rouphael, N., Johnson, R. A., Sanz, P., Anderson, E. J., Hoft, D. F., Mulligan, M. J., Ford, D. A., and Ortlund, E. A., “Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination.”, Vaccines (Basel), vol. 8, no. 3, 2020.
L. Lai, Rouphael, N., Xu, Y., Sherman, A. C., Edupuganti, S., Anderson, E. J., Lankford-Turner, P., Wang, D., Keitel, W., McNeal, M. M., Cross, K., Hill, H., Bellamy, A. R., and Mulligan, M. J., “Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
H. M. El Sahly, Gorchakov, R., Lai, L., Natrajan, M. S., Patel, S. M., Atmar, R. L., Keitel, W. A., Hoft, D. F., Barrett, J., Bailey, J., Edupuganti, S., Raabe, V., Wu, H. M., Fairley, J., Rouphael, N., Murray, K. O., and Mulligan, M. J., “Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.”, Open Forum Infect Dis, vol. 6, no. 1, p. ofy352, 2019.
S. E. Frey, Wald, A., Edupuganti, S., Jackson, L. A., Stapleton, J. T., Sahly, H. El, El-Kamary, S. S., Edwards, K., Keyserling, H., Winokur, P., Keitel, W., Hill, H., Goll, J. B., Anderson, E. L., Graham, I. L., Johnston, C., Mulligan, M., Rouphael, N., Atmar, R., Patel, S., Chen, W., Kotloff, K., C Creech, B., Chaplin, P., and Belshe, R. B., “Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.”, Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
N. Rouphael, Beck, A., Kirby, A. E., Liu, P., Natrajan, M. S., Lai, L., Phadke, V., Winston, J., Raabe, V., Collins, M. H., Girmay, T., Alvarez, A., Beydoun, N., Karmali, V., Altieri-Rivera, J., Lindesmith, L. C., Anderson, E. J., Wang, Y., El-Khorazaty, J., Petrie, C., Baric, R. S., Baqar, S., Moe, C. L., and Mulligan, M. J., “Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum”, J Infect Dis, vol. 226, no. 10, pp. 1771-1780, 2022.
A. Pegu, O'Connell, S. E., Schmidt, S. D., O'Dell, S., Talana, C. A., Lai, L., Albert, J., Anderson, E., Bennett, H., Corbett, K. S., Flach, B., Jackson, L., Leav, B., Ledgerwood, J. E., Luke, C. J., Makowski, M., Nason, M. C., Roberts, P. C., Roederer, M., Rebolledo, P. A., Rostad, C. A., Rouphael, N. G., Shi, W., Wang, L., Widge, A. T., Yang, E. Sung, Beigel, J. H., Graham, B. S., Mascola, J. R., Suthar, M. S., McDermott, A. B., Doria-Rose, N. A., Arega, J., Beigel, J. H., Buchanan, W., Elsafy, M., Hoang, B., Lampley, R., Kolhekar, A., Koo, H., Luke, C., Makhene, M., Nayak, S., Pikaart-Tautges, R., Roberts, P. C., Russell, J., Sindall, E., Albert, J., Kunwar, P., Makowski, M., Anderson, E. J., Bechnak, A., Bower, M., Camacho-Gonzalez, A. F., Collins, M., Drobeniuc, A., Edara, V. Viswanadh, Edupuganti, S., Floyd, K., Gibson, T., Ackerley, C. M. Grimsley, Johnson, B., Kamidani, S., Kao, C., Kelley, C., Lai, L., Macenczak, H., McCullough, M. Paine, Peters, E., Phadke, V. K., Rebolledo, P. A., Rostad, C. A., Rouphael, N., Scherer, E., Sherman, A., Stephens, K., Suthar, M. S., Teherani, M., Traenkner, J., Winston, J., Yildirim, I., Barr, L., Benoit, J., Carste, B., Choe, J., Dunstan, M., Erolin, R., Ffitch, J., Fields, C., Jackson, L. A., Kiniry, E., Lasicka, S., Lee, S., Nguyen, M., Pimienta, S., Suyehira, J., Witte, M., Bennett, H., Altaras, N. Emil, Carfi, A., Hurley, M., Leav, B., Pajon, R., Sun, W., Zaks, T., Coler, R. N., Larsen, S. E., Neuzil, K. M., Lindesmith, L. C., Martinez, D. R., Munt, J., Mallory, M., Edwards, C., Baric, R. S., Berkowitz, N. M., Boritz, E. A., Carlton, K., Corbett, K. S., Costner, P., Creanga, A., Doria-Rose, N. A., Douek, D. C., Flach, B., Gaudinski, M., Gordon, I., Graham, B. S., Holman, L. S., Ledgerwood, J. E., Leung, K., Lin, B. C., Louder, M. K., Mascola, J. R., McDermott, A. B., Morabito, K. M., Novik, L., O'Connell, S., O'Dell, S., Padilla, M., Pegu, A., Schmidt, S. D., Shi, W., Swanson, P. A., Talana, C. A., Wang, L., Widge, A. T., Yang, E. Sung, Zhang, Y., Chappell, J. D., Denison, M. R., Hughes, T., Lu, X., Pruijssers, A. J., Stevens, L. J., Posavad, C. M., Gale, M., Menachery, V., and Shi, P. - Y., “Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.”, Science, vol. 373, no. 6561, pp. 1372-1377, 2021.
L. Lai, Ault, K., Rouphael, N., Beck, A., Domjahn, B., Xu, Y., Anderson, E. J., Cheng, A., Nakamura, A., Hoagland, R. J., Kelley, C., Edupuganti, S., Mask, K., Nesin, M., Unger, E. R., Panicker, G., David, H., and Mulligan, M. J., “Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.”, Vaccines (Basel), vol. 8, no. 3, 2020.
E. J. Anderson, Lopman, B., Yi, J., Libster, R., C Creech, B., El-Khorazaty, J., Baqar, S., Yildirim, I., Kao, C., Rouphael, N., Shane, A. L., and Edwards, K., “Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.”, J Pediatric Infect Dis Soc, vol. 9, no. 4, pp. 479-482, 2020.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M. El, Spearman, P., Rouphael, N., Rudge, T. L., Hill, H., and Goll, J. B., “Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults.”, Vaccine, vol. 32, no. 47, pp. 6284-93, 2014.
L. A. Jackson, Chen, W. H., Stapleton, J. T., Dekker, C. L., Wald, A., Brady, R. C., Edupuganti, S., Winokur, P., Mulligan, M. J., Keyserling, H. L., Kotloff, K. L., Rouphael, N., Noah, D. L., Hill, H., and Wolff, M. C., “Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.”, J Infect Dis, vol. 206, no. 6, pp. 811-20, 2012.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., C Creech, B., Hill, H., and Bellamy, A. R., “Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.”, JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
L. Lai, Rouphael, N., Xu, Y., Kabbani, S., Beck, A., Sherman, A., Anderson, E. J., Bellamy, A., Weiss, J., Cross, K., and Mulligan, M. J., “An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.”, Vaccine, vol. 40, no. 49, pp. 7065-7072, 2022.
E. J. Anderson, Lai, L., Wrammert, J., Kabbani, S., Xu, Y., Priyamvada, L., Hill, H., Goll, J. B., Jensen, T. L., Kao, C., Yildirim, I., Rouphael, N., Jackson, L., and Mulligan, M. J., “Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
Y. - H. Chang, Duong, D. M., Goll, J. B., Wood, D. C., Jensen, T. L., Yin, L., Gelber, C. E., Seyfried, N. T., Anderson, E., Natrajan, M. S., Rouphael, N., Johnson, R. A., Sanz, P., Mulligan, M. J., and Hoft, D. F., “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
L. A. Jackson, Sahly, H. M. El, George, S., Winokur, P., Edwards, K., Brady, R. C., Rouphael, N., Keitel, W. A., Mulligan, M. J., Burton, R. L., Nakamura, A., Ferreria, J., and Nahm, M. H., “Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.”, Vaccine, vol. 36, no. 5, pp. 606-614, 2018.
L. A. Jackson, Frey, S. E., Sahly, H. M. El, Mulligan, M. J., Winokur, P. L., Kotloff, K. L., Campbell, J. D., Atmar, R. L., Graham, I., Anderson, E. J., Anderson, E. L., Patel, S. M., Fields, C., Keitel, W., Rouphael, N., Hill, H., and Goll, J. B., “Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.”, Vaccine, vol. 35, no. 13, pp. 1675-1682, 2017.
M. J. Mulligan, Bernstein, D. I., Winokur, P., Rupp, R., Anderson, E., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P., Ince, D., Noah, D. L., Hill, H., and Bellamy, A. R., “Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.”, JAMA, vol. 312, no. 14, pp. 1409-19, 2014.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., “Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.”, Vaccines (Basel), vol. 8, no. 1, 2019.
J. B. Goll, Li, S., Edwards, J. L., Bosinger, S. E., Jensen, T. L., Wang, Y., Hooper, W. F., Gelber, C. E., Sanders, K. L., Anderson, E. J., Rouphael, N., Natrajan, M. S., Johnson, R. A., Sanz, P., Hoft, D., and Mulligan, M. J., “Transcriptomic and Metabolic Responses to a Live-Attenuated Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B., “Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.”, Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.